175 related articles for article (PubMed ID: 16495731)
1. Postprostatectomy target-normal structure overlap volume differences using computed tomography and radioimmunoscintigraphy images for radiotherapy treatment planning.
Su A; Blend MJ; Spelbring D; Hamilton RJ; Jani AB
Clin Nucl Med; 2006 Mar; 31(3):139-44. PubMed ID: 16495731
[TBL] [Abstract][Full Text] [Related]
2. Impact of radioimmunoscintigraphy on definition of clinical target volume for radiotherapy after prostatectomy.
Jani AB; Spelbring D; Hamilton R; Blend MJ; Pelizzari C; Brendler C; Krauz L; Vijayakumar S; Sapra B; Weichselbaum RR
J Nucl Med; 2004 Feb; 45(2):238-46. PubMed ID: 14960642
[TBL] [Abstract][Full Text] [Related]
3. Effect of planning margin on dosimetric quality in 131Cs permanent prostate brachytherapy.
Li T; Fountain BL; Duffy EW
Brachytherapy; 2010; 9(2):159-64. PubMed ID: 19853535
[TBL] [Abstract][Full Text] [Related]
4. Anatomic variations due to radical prostatectomy. Impact on target volume definition and dose-volume parameters of rectum and bladder.
Sanguineti G; Castellone P; Foppiano F; Franzone P; Marcenaro M; Tognoni P; Bolognesi A; Ceresoli GL; Fiorino C
Strahlenther Onkol; 2004 Sep; 180(9):563-72. PubMed ID: 15378187
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the dosimetric impact of non-exclusion of the rectum from the boost PTV in IMRT treatment plans for prostate cancer patients.
Kassim I; Dirkx ML; Heijmen BJ
Radiother Oncol; 2009 Jul; 92(1):62-7. PubMed ID: 19278745
[TBL] [Abstract][Full Text] [Related]
6. Persistently better treatment planning results of intensity-modulated (IMRT) over conformal radiotherapy (3D-CRT) in prostate cancer patients with significant variation of clinical target volume and/or organs-at-risk.
Fenoglietto P; Laliberte B; Allaw A; Ailleres N; Idri K; Hay MH; Moscardo CL; Gourgou S; Dubois JB; Azria D
Radiother Oncol; 2008 Jul; 88(1):77-87. PubMed ID: 18215434
[TBL] [Abstract][Full Text] [Related]
7. Dose calculations accounting for breathing motion in stereotactic lung radiotherapy based on 4D-CT and the internal target volume.
Admiraal MA; Schuring D; Hurkmans CW
Radiother Oncol; 2008 Jan; 86(1):55-60. PubMed ID: 18082905
[TBL] [Abstract][Full Text] [Related]
8. A phase II trial for the optimisation of treatment position in the radiation therapy of prostate cancer.
O'Neill L; Armstrong J; Buckney S; Assiri M; Cannon M; Holmberg O
Radiother Oncol; 2008 Jul; 88(1):61-6. PubMed ID: 18453021
[TBL] [Abstract][Full Text] [Related]
9. A prospective three-dimensional analysis about the impact of differences in the clinical target volume in prostate cancer irradiation on normal-tissue exposure. A potential for increasing the benefit/risk ratio.
Hille A; Töws N; Schmidberger H; Hess CF
Strahlenther Onkol; 2005 Dec; 181(12):789-95. PubMed ID: 16362789
[TBL] [Abstract][Full Text] [Related]
10. Endorectal MRI assessment of local relapse after surgery for prostate cancer: A model to define treatment field guidelines for adjuvant radiotherapy in patients at high risk for local failure.
Miralbell R; Vees H; Lozano J; Khan H; Mollà M; Hidalgo A; Linero D; Rouzaud M
Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):356-61. PubMed ID: 17236961
[TBL] [Abstract][Full Text] [Related]
11. Relationship between pelvic organ-at-risk dose and clinical target volume in postprostatectomy patients receiving intensity-modulated radiotherapy.
Stanic S; Mathai M; Cui J; Purdy JA; Valicenti RK
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1897-902. PubMed ID: 21536391
[TBL] [Abstract][Full Text] [Related]
12. Breast boost: are we missing the target?
Benda RK; Yasuda G; Sethi A; Gabram SG; Hinerman RW; Mendenhall NP
Cancer; 2003 Feb; 97(4):905-9. PubMed ID: 12569589
[TBL] [Abstract][Full Text] [Related]
13. Modelling the variation in rectal dose due to inter-fraction rectal wall deformation in external beam prostate treatments.
Booth J; Zavgorodni S
Phys Med Biol; 2005 Nov; 50(21):5055-74. PubMed ID: 16237241
[TBL] [Abstract][Full Text] [Related]
14. Dosimetric consequences of intrafraction prostate motion.
Li HS; Chetty IJ; Enke CA; Foster RD; Willoughby TR; Kupellian PA; Solberg TD
Int J Radiat Oncol Biol Phys; 2008 Jul; 71(3):801-12. PubMed ID: 18234439
[TBL] [Abstract][Full Text] [Related]
15. Impact of
Jani AB; Schreibmann E; Rossi PJ; Shelton J; Godette K; Nieh P; Master VA; Kucuk O; Goodman M; Halkar R; Cooper S; Chen Z; Schuster DM
J Nucl Med; 2017 Mar; 58(3):412-418. PubMed ID: 27609792
[TBL] [Abstract][Full Text] [Related]
16. Proposal of a post-prostatectomy clinical target volume based on pre-operative MRI: volumetric and dosimetric comparison to the RTOG guidelines.
Croke J; Maclean J; Nyiri B; Li Y; Malone K; Avruch L; Kayser C; Malone S
Radiat Oncol; 2014 Dec; 9():303. PubMed ID: 25534278
[TBL] [Abstract][Full Text] [Related]
17. The effect of changing technique, dose, and PTV margin on therapeutic ratio during prostate radiotherapy.
Huang SH; Catton C; Jezioranski J; Bayley A; Rose S; Rosewall T
Int J Radiat Oncol Biol Phys; 2008 Jul; 71(4):1057-64. PubMed ID: 18339487
[TBL] [Abstract][Full Text] [Related]
18. [Changes in target volumes definition by using MRI for prostate bed radiotherapy planning--preliminary results].
Sefrová J; Paluska ; Odrázka K; Belobradek Z; Hoffmann P; Prosvic P; Brod'ák M; Louda M; Macingová Z; Vosmik M
Klin Onkol; 2010; 23(4):256-63. PubMed ID: 20806824
[TBL] [Abstract][Full Text] [Related]
19. Dosimetric effect of external beam planning preceding combined high-dose-rate brachytherapy of the prostate.
Martin JM; Brett R; Blyth J; Morrison S; Bryant D; Plank A; Cheuk R; Fay M; Dickie G; Yaxley J
Brachytherapy; 2011; 10(6):474-8. PubMed ID: 21111686
[TBL] [Abstract][Full Text] [Related]
20. Radioimmunoscintigraphy for postprostatectomy radiotherapy: analysis of toxicity and biochemical control.
Jani AB; Blend MJ; Hamilton R; Brendler C; Pelizzari C; Krauz L; Sapra B; Vijayakumar S; Awan A; Weichselbaum RR
J Nucl Med; 2004 Aug; 45(8):1315-22. PubMed ID: 15299055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]